Urinary tract cancer survival in Europe 1999–2007: Results of the population-based study EUROCARE-5
Rafael Marcos‐Gragera(Generalitat de Catalunya), Hermann Brenner(Universidad de Granada), Karri Seppä, Ladislav Dušek(Institute of Health Information and Statistics), Nadya Dimitrova(Istituto Superiore di Sanità), Margit Mägi(Universidad de Granada), Aurélien Belot, Guy Launoy(Inserm), Andrea Eberle(Leibniz Institute for Prevention Research and Epidemiology - BIPS), L. Vilardell(Generalitat de Catalunya), Jean Faivre(Institut de Cancérologie de Lorraine), Mario Šekerija(London Cancer), Gerda Engholm(National Board of Health and Welfare), Núria Malats(Spanish National Cancer Research Centre), Pascale Grosclaude(Seoul National University Children's Hospital), Lambertus A. Kiemeney(Radboud University Nijmegen), Florence Molinié, Hans H. Storm(Danish Cancer Society), K. Henau, Anne‐Sophie Woronoff, Alain Monnereau, Michel Robaszkiewicz(Universidad de Granada), Sandra Mallone(Istituto Superiore di Sanità), Nadine Bossard(Istituto Superiore di Sanità), Milena Sant(Fondazione IRCCS Istituto Nazionale dei Tumori), Véronique Bouvier(Inserm), Tiiu Aareleid(Fondazione IRCCS Istituto Nazionale dei Tumori), Marc Colonna(Universidad de Granada), Anne‐Marie Bouvier(Inserm), Z. Valerianova(Istituto Superiore di Sanità), Nea Malila(Istituto Superiore di Sanità), X. Troussard, Yves Allory(Institut Curie), Miroslav Zvolský(Institute of Health Information and Statistics), Willi Oberaigner, M. Meyer(Universidad de Granada), Anne‐Valérie Guizard, B. Lapôtre‐Ledoux(Fondazione IRCCS Istituto Nazionale dei Tumori), Monika Hackl(Universidad de Granada), Roland Stabenow(Fondazione IRCCS Istituto Nazionale dei Tumori), S. Bara(Fondazione IRCCS Istituto Nazionale dei Tumori), Sabine Luttmann(Fondazione IRCCS Istituto Nazionale dei Tumori), Michel Velten(Pancreatic Cancer Action Network), M. Maynadié(Université de Bourgogne), E. Van Eycken(Istituto Superiore di Sanità), Brigitte Trétarre(Queen's University Belfast), Claire Schvartz(Fondazione IRCCS Istituto Nazionale dei Tumori), Isabelle Baldi(Pancreatic Cancer Action Network), P. Arveux, N. Zielonke(Istituto Superiore di Sanità)
Cited by 90
Related Papers
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015
|The Lancet|2017|2.1k
Common variants conferring risk of schizophrenia
|Nature|2009|1.7k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k